Biofilm stimulating activity of solanidine and Solasodine in Pseudomonas aeruginosa.
Journal
BMC microbiology
ISSN: 1471-2180
Titre abrégé: BMC Microbiol
Pays: England
ID NLM: 100966981
Informations de publication
Date de publication:
02 08 2023
02 08 2023
Historique:
received:
27
02
2023
accepted:
21
07
2023
medline:
4
8
2023
pubmed:
3
8
2023
entrez:
2
8
2023
Statut:
epublish
Résumé
Biofilm formation has reported as an important virulence associated properties of Pseudomonas aeruginosa that is regulated by quorum-sensing associated genes. Biofilm and quorum-sensing interfering properties of steroidal alkaloids, Solanidine and Solasodine were investigated in the present study. Biofilm formation capacity and relative expression level of five studied genes(lasI, lasR, rhlI, rhlR and algD) were significantly increased dose-dependently after treatment with sub-inhibitory concentrations (32 and 512 µg/ml) of the both Solanidine and Solasodine. Biofilm formation capacity was more stimulated in weak biofilm formers(9 iaolates) in comparison to the strong biofilm producers(11 isolates). The lasI gene was the most induced QS-associated gene among five investigated genes. Biofilm inducing properties of the plants alkaloids and probably medicines derived from them has to be considered for revision of therapeutic guidelines. Investigating the biofilm stimulating properties of corticosteroids and other medicines that comes from plant alkaloids also strongly proposed.
Sections du résumé
BACKGROUND
Biofilm formation has reported as an important virulence associated properties of Pseudomonas aeruginosa that is regulated by quorum-sensing associated genes. Biofilm and quorum-sensing interfering properties of steroidal alkaloids, Solanidine and Solasodine were investigated in the present study.
RESULTS
Biofilm formation capacity and relative expression level of five studied genes(lasI, lasR, rhlI, rhlR and algD) were significantly increased dose-dependently after treatment with sub-inhibitory concentrations (32 and 512 µg/ml) of the both Solanidine and Solasodine. Biofilm formation capacity was more stimulated in weak biofilm formers(9 iaolates) in comparison to the strong biofilm producers(11 isolates). The lasI gene was the most induced QS-associated gene among five investigated genes.
CONCLUSION
Biofilm inducing properties of the plants alkaloids and probably medicines derived from them has to be considered for revision of therapeutic guidelines. Investigating the biofilm stimulating properties of corticosteroids and other medicines that comes from plant alkaloids also strongly proposed.
Identifiants
pubmed: 37533040
doi: 10.1186/s12866-023-02957-z
pii: 10.1186/s12866-023-02957-z
pmc: PMC10394856
doi:
Substances chimiques
solasodine
L40Y453Y96
solanidine
W7801OHM8B
Virulence Factors
0
Bacterial Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
208Informations de copyright
© 2023. The Author(s).
Références
Appl Microbiol Biotechnol. 2019 Apr;103(8):3521-3535
pubmed: 30852658
Microbes Infect. 2022 Jun;24(4):104950
pubmed: 35139390
Int J Antimicrob Agents. 2014 Nov;44(5):377-86
pubmed: 25130096
Nat Protoc. 2008;3(6):1101-8
pubmed: 18546601
Microbiology (Reading). 2010 Aug;156(Pt 8):2271-2282
pubmed: 20488878
Sci Rep. 2020 Apr 14;10(1):6364
pubmed: 32286447
J Antimicrob Chemother. 2000 Mar;45(3):315-20
pubmed: 10702550
Biofouling. 2017 Sep;33(8):624-639
pubmed: 28792229
Biomol Ther (Seoul). 2016 Nov 1;24(6):561-571
pubmed: 27795450
APMIS. 2007 Aug;115(8):891-9
pubmed: 17696944
Infect Drug Resist. 2020 Aug 12;13:2801-2810
pubmed: 32848429
Trends Microbiol. 2018 Apr;26(4):313-328
pubmed: 29132819
Microb Pathog. 2017 Oct;111:99-107
pubmed: 28818490
PLoS One. 2015 Mar 17;10(3):e0119564
pubmed: 25781975
Signal Transduct Target Ther. 2022 Jun 25;7(1):199
pubmed: 35752612
Antimicrob Resist Infect Control. 2019 Jul 16;8:118
pubmed: 31346459
Biotechnol Adv. 2021 Jul-Aug;49:107734
pubmed: 33785375
Protein Cell. 2015 Jan;6(1):26-41
pubmed: 25249263
J Adv Res. 2017 Jan;8(1):55-61
pubmed: 28053782
PLoS Pathog. 2019 Mar 20;15(3):e1007511
pubmed: 30893371
BMC Pharmacol Toxicol. 2018 Feb 13;19(1):7
pubmed: 29439722
J Med Microbiol. 2004 Sep;53(Pt 9):841-853
pubmed: 15314190
Appl Environ Microbiol. 2009 Aug;75(15):5131-40
pubmed: 19525275
Appl Environ Microbiol. 2001 Apr;67(4):1865-73
pubmed: 11282644
Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):17981-6
pubmed: 24143808
Antimicrob Agents Chemother. 2008 Apr;52(4):1446-53
pubmed: 18195062
Int J Cancer. 2019 Oct 1;145(7):1731-1744
pubmed: 30387881
Microorganisms. 2022 Jun 16;10(6):
pubmed: 35744757
Antimicrob Agents Chemother. 2012 Aug;56(8):4131-9
pubmed: 22615276
Eur J Med Chem. 2014 Jun 10;80:605-20
pubmed: 24877760
Biotechnol Lett. 2018 Jul;40(7):1087-1100
pubmed: 29680931
Curr Opin Microbiol. 2018 Oct;45:164-169
pubmed: 30053750
Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):7027-7032
pubmed: 30850547
Microb Pathog. 2019 Jun;131:128-134
pubmed: 30959097
BMC Microbiol. 2010 Jan 30;10:33
pubmed: 20113519
Drug Discov Today. 2019 Jan;24(1):350-359
pubmed: 30036575
Drugs. 2021 Dec;81(18):2117-2131
pubmed: 34743315
EMBO Mol Med. 2015 Jun 15;7(8):992-3
pubmed: 26077592
Antimicrob Agents Chemother. 2018 May 25;62(6):
pubmed: 29610201
J Antimicrob Chemother. 2012 Mar;67(3):559-68
pubmed: 22129590
Int J Artif Organs. 2011 Sep;34(9):737-51
pubmed: 22094552
Mol Pharm. 2015 May 4;12(5):1544-53
pubmed: 25793309
BMC Complement Altern Med. 2019 Jul 18;19(1):177
pubmed: 31319827
Int J Mol Sci. 2019 Apr 13;20(8):
pubmed: 31013936
J Microsc Ultrastruct. 2018 Jan-Mar;6(1):1-10
pubmed: 30023261